RPRX soon will have PDUFA. Buy at $7. Going back to 52 week high of $22 before PDUFA.
I only recently started a long position in IRWD. I prefer to buy low.
No, IRWD has liquid assets of $308 million, vs liabilities of $237 million, $160 million of which is longterm debt. You must have added in the over $1 billion in accumulated operating losses, which is actually a highly attractive item for a potential acquirer.
1/2 BILLION in debt, right? on 90 million in gross revs, right?
Right.... you take SGYP. I'l stick with IRWD. Let's check back in a year and see who's ahead..
According to the newer study, Linzess's superiority to the SGYP drug is even more marked. In the earlier SGYP study, the two dosages were 10.8% and 9.3% superior to the placebo. In the newer study, the dosages were only 7.2% and 7.3% superior to the placebo. The Linzess dosages were 17% and 9.9% superior to placebo. The slightly lower diarrhea occurrence for the SGYP drug can be attributed to the fact that it just doesn't work very well. Which is also demonstrated by the fact that the higher dosage doesn't work any better than the lower dosage. There is a large psychological component to these results. Otherwise why would people who are chronically constipated report that the placebo gave them diarrhea?
The only miracle is that people can stop the soup from running down their leg and into their shoe. This pig is setting 52 week lows each day
Maybe they are dumping SGYP to retail after the recent pump, while accumulating IRWD after the recent MS downgrade. Ya know... that pesky 'smart money' thing...
i am short now. the typical online idiot basher. a nobody speaking nothing and non-sense.
Chart shows buying just beginning to accelerate.
Millennium Healthcare (MHCC) reported revenues increased over 400% in 2014 to over $8 million
Total market cap today at $0.01 per share equals less than $2 million.
At only 10X revenues shares should be selling at $.45 today.
Aggressive growth - Recently acquired HealthPath and MedX with more to be announced
Revenues set to explode again in 2015.
New management is very strong, capable and with strong healthcare relationships.
Expect big runway of new FDA approved early detection diagnostics for heart and cancer.
Small investment has potential for very big gains this year.
Keep MHCC in your portfolio and watch closely for frequent news of big changes
MHCC 12 month price target - $1.25
Sentiment: Strong Buy
What step is that? The step of announcing positive phase 3 data? You make no sense.